Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
ImmunoGen Appoints Isabel Kalofonos as Senior Vice President and Chief Commercial Officer
ImmunoGen, a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of […]
Strand Therapeutics Appoints Colleen Wilson as Chief People Officer
Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, today […]
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer
ImmVira, a biotechnology company focused on developing and synthesizing biological vector delivery platform, has announced […]
Areteia Therapeutics Announces Appointment of Elyse Stock, M.D. To Board of Directors
Areteia Therapeutics, today announced the appointment of Elyse Stock to the Areteia Board of Directors, […]
Cardurion Pharmaceuticals Further Bolsters Leadership Team with Appointment of Stephen Migausky as General Counsel
Cardurion Pharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation […]
Engimmune Therapeutics Appoints Dr. Lars Nieba as Chief Executive Officer
Engimmune Therapeutics, a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, today announces the […]
Ocelot Bio Appoints Lise Kjems, M.D., Ph.D., as Chief Medical Officer
Ocelot Bio, a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics to treat […]
YDS Pharmatech Appoints Dr. Robert Sullivan as Head of Medicinal Chemistry
YDS Pharmatech, a computational drug discovery company specializing in induced proximity, today announced the appointment […]
Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced […]
Sherlock Biosciences Appoints Maurice Exner as Chief Scientific Officer
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more